Latest News - Chemence Medical, Inc.

5
May

Chemence Opens New Research and Development Facility

Chemence Center of Excellence to focus on adhesive technology innovation

Alpharetta, GA — Chemence, a global company with specialized expertise in the field of polymerizable technology, announced the opening of the Chemence Center of Excellence, a state-of-the-art research and development facility in Alpharetta, Georgia.

Read more

9
Apr

Chemence Medical Receives FDA Approval for Exofin Fusion® Redesign

Medical technologies manufacturer improves patient care with enhanced skin closure system

Alpharetta, GA — Chemence Medical, a world leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion® skin closure system.

Read more

25
Feb

Chemence Medical Receives FDA Clearance for Exofin® Tissue Adhesive

Alpharetta, Georgia – February 15, 2016

Chemence Medical, Inc., a manufacturer and distributor of adhesive-based medical devices, announced it received Food and Drug Administration clearance to market and sell Exofin®, a new topical skin adhesive for wound closure. Exofin enters the market as the fastest polymerizing 2-octyl cyanoacrylate topical adhesive available and as the highest viscosity formulation in the industry. Read more